Medicare Enrolled

Dr. Rachel Chandler, MD

Dermatology · Midland, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5117 SUNMORE CIR, Midland, TX 79707
4326892512
In practice since 2007 (18 years)
NPI: 1396937280 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chandler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chandler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chandler

Dr. Rachel Chandler is a dermatology in Midland, TX, with 18 years in practice. Based on federal Medicare data, Dr. Chandler performed 9,267 Medicare services across 4,367 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chandler received a total of $8,032 from 37 pharmaceutical and/or device companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chandler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 10% volume in TX$ $8,032 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,267
Medicare services
Top 10% in TX for dermatology
4,367
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~515 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-144,485$5$20
Office visit, established patient (20-29 min)1,706$55$260
Destruction of precancerous skin growth, 11,116$34$195
Destruction of skin growths (warts/lesions), 1-14609$76$330
Skin biopsy, tangential375$58$300
New patient office visit (30-44 min)205$66$320
Destruction of precancer skin growth, 15 or more growths163$117$490
Office visit, established patient (10-19 min)128$36$160
Biopsy of related skin growth, each additional growth81$36$150
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm65$210$880
Destruction of skin growth, 15 or more growths43$88$385
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm32$99$710
Biopsy of ear32$51$280
Office visit, established patient (30-39 min)32$79$370
Steroid injection (triamcinolone)28$1$5
Injection into skin growth, 1-7 growths21$28$165
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm21$117$520
Acne surgery18$79$335
Punch biopsy, first skin growth18$79$370
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm18$109$805
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm18$236$905
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm15$63$500
Simple or single drainage of skin abscess14$97$360
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm13$99$730
New patient office or other outpatient visit, 15-29 minutes11$35$210
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
6.0% medium
93.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,032
Total received (2018-2024)
Avg $1,147/year across 7 years
Top 34% in TX for dermatology
37
Companies
425
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,720 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (3.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,329
2023
$1,554
2022
$1,543
2021
$1,248
2020
$597
2019
$1,062
2018
$699

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$977
Regeneron Healthcare Solutions, Inc.
$813
AbbVie Inc.
$654
Janssen Biotech, Inc.
$634
ABBVIE INC.
$512
Novartis Pharmaceuticals Corporation
$454
Mayne Pharma Inc.
$403
PFIZER INC.
$289
Galderma Laboratories, L.P.
$283
Allergan, Inc.
$275
E.R. Squibb & Sons, L.L.C.
$266
Nevro Corp.
$252
AbbVie, Inc.
$245
MAYNE PHARMA INC.
$217
Lilly USA, LLC
$205
LEO Pharma Inc.
$174
Sun Pharmaceutical Industries Inc.
$162
Celgene Corporation
$139
Ortho Dermatologics, a division of Bausch Health US, LLC
$131
UCB, Inc.
$107
MAYNE PHARMA COMMERCIAL LLC
$98
Incyte Corporation
$93
Arcutis Biotherapeutics, Inc.
$73
Janssen Scientific Affairs, LLC
$69
GENZYME CORPORATION
$66
Almirall LLC
$59
iCAD, Inc
$59
SUN PHARMACEUTICAL INDUSTRIES INC.
$54
Journey Medical Corporation
$45
Biofrontera Inc.
$41
Genentech USA, Inc.
$40
Kerecis Limited
$37
Lifenet Health
$33
Merck Sharp & Dohme LLC
$23
DERMIRA, INC.
$21
ORGANOGENESIS INC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 30.4% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · ARAZLO · AXXENT SURFACE CONTROLLER · Ameluz · BOTOX · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · KEYTRUDA · KLISYRI · Kerecis Omega3 SurgiClose · Klisyri · LIBTAYO · OPZELURA · ORACEA · Otezla · Puraply · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Senza Spinal Cord Stimulation System · Skyrizi · Sotyktu · TALTZ · TREMFYA · TheraGenesis Wound Matrix · Tremfya · Winlevi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $87 per 100 Medicare services performed
Looking for a dermatology in Midland?
Compare dermatologys in the Midland area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
7
Per 100K population
4.1
County median income
$93,984
Nearest hospital
MIDLAND MEMORIAL HOSPITAL
7.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chandler is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chandler experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Chandler performed 4,485 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chandler receive payments from pharmaceutical companies?
Yes. Dr. Chandler received a total of $8,032 from 37 companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chandler's costs compare to other dermatologys in Midland?
Dr. Chandler's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chandler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →